Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 3c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 3c; Issues Mixed Outlook
May 6, 2025 6:59 AM EDT
BofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $28.00 (from $26.00) while maintaining a Underperform rating.
The analyst comments "Following this quarters earnings, we see a wider range of outcomes for full year revenue (link to our first take here). In the first scenario, if HIMS were to grow its... More
May 6, 2025 6:19 AM EDT
Leerink Partners analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $42.00 (from $40.00) while maintaining a Market Perform rating.
The analyst comments "HIMS's 2Q earnings touched on a number of key flash points as the company shifts to the next generation of GLP-1... More
May 6, 2025 4:58 AM EDT
BofA Securities analyst Michael Cherny reiterated an Underperform rating and $26.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments "HIMS reported a strong quarter, with revenue of $586MM well ahead of the guidance/consensus and slightly ahead of BofAs estimate of $583.1MM. Second quarter... More
